Questions re generic IPE vs brand Vascepa | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  7855 of 8065  at  11/25/2020 3:50:06 PM  by

cmm3rd


 In response to msg 7852 by  ex_hacker202
view thread

Re: Questions re generic IPE vs brand Vascepa

AB rating means it's therapeutically equivalent to brand name ... docs will rightly assume that GV should work just as well for the R-IT indication -
 
Physicians might make that assumption, but would it be "right"?  You say it would; JT says it would not (or at least that the AB therapeutic equivalence rating applies only to severe hypertriglyceridemia).  If JT is correct, Amarin should educate physicians to such effect, disabusing them of their assumption.
 
Are you so confident of your research that you are satisfied that your two, 0.5 gram capsules of Vascepa are the therapeutic equivalent of one, 1 gram capsule of Hikma's IPE for whatever indication you are taking it, such that you will take Hikma's product and believe it is having the same effect as did Amarin's product?
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
7856 Re: Questions re generic IPE vs brand Vascepa ex_hacker202 0 11/26/2020 4:10:27 PM








Financial Market Data provided by
.
Loading...